Found: 141
Select item for more details and to access through your institution.
Correction: Effectiveness of a Web-Based Tailored Intervention With Virtual Assistants Promoting the Acceptability of HPV Vaccination Among Mothers of Invited Girls: Randomized Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 4, p. 634, doi. 10.1093/infdis/jiab250
- By:
- Publication type:
- Article
Mumps Serum Antibody Levels Before and After an Outbreak to Assess Infection and Immunity in Vaccinated Students.
- Published in:
- Open Forum Infectious Diseases, 2014, v. 1, n. 3, p. 1, doi. 10.1093/ofid/ofu101
- By:
- Publication type:
- Article
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10020-6
- By:
- Publication type:
- Article
Clinical Characterization of Invasive Disease Caused by Haemophilus influenzae Serotype b in a High Vaccination Coverage Setting.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2019, v. 8, n. 3, p. 261, doi. 10.1093/jpids/piy020
- By:
- Publication type:
- Article
Economic Costs of Measles Outbreak in the Netherlands, 2013-2014.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009-2012.
- Published in:
- Emerging Infectious Diseases, 2014, v. 20, n. 4, p. 643, doi. 10.3201/eid2004.131681
- By:
- Publication type:
- Article
Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands.
- Published in:
- Emerging Infectious Diseases, 2012, v. 18, n. 11, p. 1729
- By:
- Publication type:
- Article
Mumps Vaccine Effectiveness Against Orchitis.
- Published in:
- Emerging Infectious Diseases, 2012, v. 18, n. 1, p. 191, doi. 10.3201/eid1801.111178
- By:
- Publication type:
- Article
Seroprevalence of trichodysplasia spinulosa-associated polyomavirus.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Seroprevalence of Trichodysplasia Spinulosa-associated Polyomavirus.
- Published in:
- Emerging Infectious Diseases, 2011, v. 17, n. 8, p. 1355, doi. 10.3201/eid1708.110114
- By:
- Publication type:
- Article
Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands.
- Published in:
- Emerging Infectious Diseases, 2010, v. 16, n. 5, p. 816, doi. 10.3201/eid1605.091223
- By:
- Publication type:
- Article
Measles Outbreak, the Netherlands, 2008.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Parental reports of adverse events following simultaneously given dT-IPV and MMR vaccines in healthy 9-year-old children.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31838-8
- By:
- Publication type:
- Article
Factors potentially contributing to the decline of the mpox outbreak in the Netherlands, 2022 and 2023.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 21, p. 27, doi. 10.2807/1560-7917.ES.2024.29.21.2300608
- By:
- Publication type:
- Article
Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 10, p. 8, doi. 10.2807/1560-7917.ES.2024.29.10.2400109
- By:
- Publication type:
- Article
Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December 2023.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 1, p. 2, doi. 10.2807/1560-7917.ES.2024.29.1.2300703
- By:
- Publication type:
- Article
Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 7, p. 31, doi. 10.2807/1560-7917.ES.2023.28.7.2200724
- By:
- Publication type:
- Article
Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 7, p. 2, doi. 10.2807/1560-7917.ES.2023.28.7.2300087
- By:
- Publication type:
- Article
Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 1, p. 8, doi. 10.2807/1560-7917.ES.2023.28.1.2200941
- By:
- Publication type:
- Article
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 45, p. 1, doi. 10.2807/1560-7917.ES.2022.27.45.2200217
- By:
- Publication type:
- Article
A scenario modelling analysis to anticipate the impact of COVID-19 vaccination in adolescents and children on disease outcomes in the Netherlands, summer 2021.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 44, p. 28, doi. 10.2807/1560-7917.ES.2022.27.44.2101090
- By:
- Publication type:
- Article
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.
- Published in:
- Eurosurveillance (15607917), 2021, v. 26, n. 44, p. 2, doi. 10.2807/1560-7917.ES.2021.26.44.2100977
- By:
- Publication type:
- Article
Increase in invasive disease caused by Haemophilus influenzae b, the Netherlands, 2020 to 2021.
- Published in:
- Eurosurveillance (15607917), 2021, v. 26, n. 42, p. 9, doi. 10.2807/1560-7917.ES.2021.26.42.2100956
- By:
- Publication type:
- Article
Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.
- Published in:
- Eurosurveillance (15607917), 2021, v. 26, n. 31, p. 7, doi. 10.2807/1560-7917.ES.2021.26.31.2100640
- By:
- Publication type:
- Article
Impact of physical distancing measures against COVID-19 on contacts and mixing patterns: repeated cross-sectional surveys, the Netherlands, 2016-17, April 2020 and June 2020.
- Published in:
- Eurosurveillance (15607917), 2021, v. 26, n. 8, p. 19, doi. 10.2807/1560-7917.ES.2021.26.8.2000994
- By:
- Publication type:
- Article
Disease burden of varicella versus other vaccinepreventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 18, p. 1, doi. 10.2807/1560-7917.ES.2019.24.18.1800363
- By:
- Publication type:
- Article
SARS‐CoV‐2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future Response.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 6, p. 1, doi. 10.1111/irv.13312
- By:
- Publication type:
- Article
Investigating sources of non-response bias in a population-based seroprevalence study of vaccine-preventable diseases in the Netherlands.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09095-5
- By:
- Publication type:
- Article
Maternal vaccination against pertussis as part of the national immunization program: a qualitative evaluation among obstetric care providers one year after the implementation in December 2019.
- Published in:
- BMC Health Services Research, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12913-023-09274-1
- By:
- Publication type:
- Article
Review: Current knowledge on the role of HPV antibodies after natural infection and vaccination: Implications for monitoring an HPV vaccination programme.
- Published in:
- Journal of Medical Virology, 2013, v. 85, n. 8, p. 1379, doi. 10.1002/jmv.23616
- By:
- Publication type:
- Article
Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1409, doi. 10.3390/vaccines11091409
- By:
- Publication type:
- Article
Additional Evidence on Serological Correlates of Protection against Measles: An Observational Cohort Study among Once Vaccinated Children Exposed to Measles.
- Published in:
- Vaccines, 2019, v. 7, n. 4, p. 158, doi. 10.3390/vaccines7040158
- By:
- Publication type:
- Article
Seroepidemiology of Measles, Mumps and Rubella on Bonaire, St. Eustatius and Saba: The First Population-Based Serosurveillance Study in Caribbean Netherlands.
- Published in:
- Vaccines, 2019, v. 7, n. 4, p. 137, doi. 10.3390/vaccines7040137
- By:
- Publication type:
- Article
Underreporting of Meningococcal Disease Incidence in the Netherlands: Results from a Capture–Recapture Analysis Based on Three Registration Sources with Correction for False Positive Diagnoses.
- Published in:
- European Journal of Epidemiology, 2006, v. 21, n. 4, p. 315, doi. 10.1007/s10654-006-0020-z
- By:
- Publication type:
- Article
Space-Time Cluster Analysis of Invasive Meningococcal Disease.
- Published in:
- Emerging Infectious Diseases, 2004, v. 10, n. 9, p. 1621, doi. 10.3201/eid1009.030992
- By:
- Publication type:
- Article
Measles Outbreak in a Community with Very Low Vaccine Coverage, the Netherlands.
- Published in:
- Emerging Infectious Diseases, 2001, v. 7, n. 3, p. 593, doi. 10.3201/eid0703.010343
- By:
- Publication type:
- Article
Reemergence of Pertussis in the Highly Vaccinated Population of the Netherlands: Observations on Surveillance Data.
- Published in:
- Emerging Infectious Diseases, 2000, v. 6, n. 4, p. 348
- By:
- Publication type:
- Article
Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dutch national immunization schedule: compliance and associated characteristics for the primary series.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Vaccine uptake determinants in The Netherlands.
- Published in:
- European Journal of Public Health, 2014, v. 24, n. 2, p. 304, doi. 10.1093/eurpub/ckt042
- By:
- Publication type:
- Article
Health-related quality of life during the COVID-19 pandemic: The impact of restrictive measures using data from two Dutch population-based cohort studies.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0300324
- By:
- Publication type:
- Article
Evaluation of the surveillance system for invasive meningococcal disease (IMD) in the Netherlands, 2004-2016.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years.
- Published in:
- European Journal of Epidemiology, 2022, v. 37, n. 10, p. 1035, doi. 10.1007/s10654-022-00895-0
- By:
- Publication type:
- Article